Dynavax Technologies Corp (NASDAQ: DVAX) has a higher price-to-earnings ratio of 59.76x compared to its average ratio, The 36-month beta value for DVAX is at 1.32. Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for DVAX is 118.47M, and currently, shorts hold a 15.53% of that float. The average trading volume for DVAX on April 22, 2025 was 2.44M shares.
DVAX) stock’s latest price update
The stock of Dynavax Technologies Corp (NASDAQ: DVAX) has increased by 1.26 when compared to last closing price of 10.31. Despite this, the company has experienced a -7.20% fall in its stock price over the last five trading sessions. businesswire.com reported 2025-04-21 that GREENWICH, Conn.–(BUSINESS WIRE)–Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders of Dynavax Technologies Corporation (NASDAQ: DVAX) (“Dynavax”, “DVAX” or the “Company”), with ownership of approximately 14.53% of the Company’s outstanding shares, today announced that it has filed a definitive proxy statement in connection with its nomination of four highly qualified candidates for election to the Company’s Board of Directors (the “B.
DVAX’s Market Performance
DVAX’s stock has fallen by -7.20% in the past week, with a monthly drop of -23.35% and a quarterly drop of -16.14%. The volatility ratio for the week is 4.29% while the volatility levels for the last 30 days are 4.33% for Dynavax Technologies Corp The simple moving average for the last 20 days is -14.98% for DVAX stock, with a simple moving average of -13.54% for the last 200 days.
Analysts’ Opinion of DVAX
Many brokerage firms have already submitted their reports for DVAX stocks, with Goldman repeating the rating for DVAX by listing it as a “Sell.” The predicted price for DVAX in the upcoming period, according to Goldman is $12 based on the research report published on February 11, 2025 of the current year 2025.
Goldman, on the other hand, stated in their research note that they expect to see DVAX reach a price target of $20. The rating they have provided for DVAX stocks is “Neutral” according to the report published on February 01st, 2024.
JMP Securities gave a rating of “Mkt Outperform” to DVAX, setting the target price at $22 in the report published on September 27th of the previous year.
DVAX Trading at -19.87% from the 50-Day Moving Average
After a stumble in the market that brought DVAX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.64% of loss for the given period.
Volatility was left at 4.33%, however, over the last 30 days, the volatility rate increased by 4.29%, as shares sank -24.46% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -20.37% lower at present.
During the last 5 trading sessions, DVAX fell by -7.20%, which changed the moving average for the period of 200-days by -5.78% in comparison to the 20-day moving average, which settled at $12.28. In addition, Dynavax Technologies Corp saw -18.25% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DVAX starting from Novack David F, who sale 10,000 shares at the price of $14.00 back on Mar 24 ’25. After this action, Novack David F now owns 8,078 shares of Dynavax Technologies Corp, valued at $140,000 using the latest closing price.
DAVID NOVACK, the Officer of Dynavax Technologies Corp, proposed sale 10,000 shares at $14.00 during a trade that took place back on Mar 24 ’25, which means that DAVID NOVACK is holding shares at $140,000 based on the most recent closing price.
Stock Fundamentals for DVAX
Current profitability levels for the company are sitting at:
- -0.01 for the present operating margin
- 0.82 for the gross margin
The net margin for Dynavax Technologies Corp stands at 0.1. The total capital return value is set at -0.0. Equity return is now at value 4.48, with 2.75 for asset returns.
Based on Dynavax Technologies Corp (DVAX), the company’s capital structure generated 0.3 points at debt to capital in total, while cash flow to debt ratio is standing at 0.26. The debt to equity ratio resting at 0.43. The interest coverage ratio of the stock is -0.35.
Currently, EBITDA for the company is 45.7 million with net debt to EBITDA at 4.79. When we switch over and look at the enterprise to sales, we see a ratio of 5.25. The receivables turnover for the company is 5.91for trailing twelve months and the total asset turnover is 0.28. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.80.
Conclusion
In conclusion, Dynavax Technologies Corp (DVAX) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
